CBIO

CBIO's proprietary Intrepid Microfluidics platform can be used to study live cells. CBIO's technology identifies subtle differences between normal and abnormal live cells, preserves functionality, and maintains availability for further research. CBIO's approach reduces the need for genetic analysis, eliminates inefficiencies commonly associated with single-cell analysis, and identifies subcellular differences found within intact cells.